+Search query
-Structure paper
Title | Identification of the Clinical Development CandidateMRTX849, a Covalent KRASG12CInhibitor for the Treatment of Cancer. |
---|---|
Journal, issue, pages | J. Med. Chem., Vol. 63, Page 6679-6693, Year 2020 |
Publish date | Oct 28, 2019 (structure data deposition date) |
Authors | Fell, J.B. / Fischer, J.P. / Baer, B.R. / Blake, J.F. / Bouhana, K. / Briere, D.M. / Brown, K.D. / Burgess, L.E. / Burns, A.C. / Burkard, M.R. ...Fell, J.B. / Fischer, J.P. / Baer, B.R. / Blake, J.F. / Bouhana, K. / Briere, D.M. / Brown, K.D. / Burgess, L.E. / Burns, A.C. / Burkard, M.R. / Chiang, H. / Chicarelli, M.J. / Cook, A.W. / Gaudino, J.J. / Hallin, J. / Hanson, L. / Hartley, D.P. / Hicken, E.J. / Hingorani, G.P. / Hinklin, R.J. / Mejia, M.J. / Olson, P. / Otten, J.N. / Rhodes, S.P. / Rodriguez, M.E. / Savechenkov, P. / Smith, D.J. / Sudhakar, N. / Sullivan, F.X. / Tang, T.P. / Vigers, G.P. / Wollenberg, L. / Christensen, J.G. / Marx, M.A. |
External links | J. Med. Chem. / PubMed:32250617 |
Methods | X-ray diffraction |
Resolution | 1.94 - 2.27 Å |
Structure data | PDB-6usx: PDB-6usz: PDB-6ut0: |
Chemicals | ChemComp-GDP: ChemComp-MG: ChemComp-M1R: ChemComp-HOH: ChemComp-QH4: ChemComp-M1X: |
Source |
|
Keywords | HYDROLASE/INHIBITOR / Hydrolase inhibitor / HYDROLASE / HYDROLASE-INHIBITOR complex |